Financial results - BIO CHRIS PHARMA S.R.L.

Financial Summary - Bio Chris Pharma S.r.l.
Unique identification code: 38730452
Registration number: J08/154/2018
Nace: 4729
Sales - Ron
176.049
Net Profit - Ron
13.901
Employees
1
Open Account
Company Bio Chris Pharma S.r.l. with Fiscal Code 38730452 recorded a turnover of 2024 of 176.049, with a net profit of 13.901 and having an average number of employees of 1. The company operates in the field of Comert cu amanuntul al altor produse alimentare, in magazine specializate having the NACE code 4729.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Bio Chris Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 42.209 72.212 91.127 79.138 83.721 116.921 176.049
Total Income - EUR - - - 42.209 72.212 91.127 79.138 83.721 116.921 176.512
Total Expenses - EUR - - - 46.309 66.873 79.128 76.709 81.346 112.228 160.148
Gross Profit/Loss - EUR - - - -4.100 5.339 12.000 2.429 2.375 4.693 16.364
Net Profit/Loss - EUR - - - -4.522 4.224 10.721 1.727 1.083 3.857 13.901
Employees - - - 2 1 1 1 2 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 51.4%, from 116.921 euro in the year 2023, to 176.049 euro in 2024. The Net Profit increased by 10.065 euro, from 3.857 euro in 2023, to 13.901 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Bio Chris Pharma S.r.l.

Rating financiar

Financial Rating -
BIO CHRIS PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Bio Chris Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bio Chris Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Bio Chris Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bio Chris Pharma S.r.l. - CUI 38730452

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 979 932 824 529 292 0 10.000
Current Assets - - - 5.007 7.084 11.655 10.178 10.253 23.095 23.076
Inventories - - - 4.378 6.175 7.677 7.972 8.393 18.486 18.766
Receivables - - - 0 0 1.244 1.182 1.108 2.952 2.455
Cash - - - 629 909 2.735 1.024 751 1.658 1.854
Shareholders Funds - - - -4.479 -169 10.555 6.622 1.328 5.138 19.010
Social Capital - - - 43 42 41 40 41 40 40
Debts - - - 10.478 8.243 2.110 4.085 9.216 17.957 14.325
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4729 - 4729"
CAEN Financial Year 4729
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 23.076 euro in 2024 which includes Inventories of 18.766 euro, Receivables of 2.455 euro and cash availability of 1.854 euro.
The company's Equity was valued at 19.010 euro, while total Liabilities amounted to 14.325 euro. Equity increased by 13.901 euro, from 5.138 euro in 2023, to 19.010 in 2024.

Risk Reports Prices

Reviews - Bio Chris Pharma S.r.l.

Comments - Bio Chris Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.